Evidence map›Paper›PMID 27338814›Full record

ArticleActa neuropathologica communications2016

Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease.

Amit K Chouhan, Caiwei Guo, Yi-Chen Hsieh, Hui Ye, Mumine Senturk, Zhongyuan Zuo, Yarong Li, Shreyasi Chatterjee, Juan Botas, George R Jackson and 2 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Alzheimer's disease pathophysiology in the Retina.Progress in retinal and eye research · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Amit K ChouhanDepartment of Neurology, Baylor College of Medicine, Houston, TX, 77030, USA.
Caiwei GuoDepartment of Neuroscience, Baylor College of Medicine, Houston, TX, 77030, USA.
Yi-Chen HsiehDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Hui YeDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Mumine SenturkProgram in Developmental Biology, Baylor College of Medicine, Houston, TX, 77030, USA.
Zhongyuan ZuoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Yarong LiDepartment of Neurology, Baylor College of Medicine, Houston, TX, 77030, USA.
Shreyasi ChatterjeeDepartment of Neurology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Juan BotasDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
George R JacksonDepartment of Neurology, Baylor College of Medicine, Houston, TX, 77030, USA.
Hugo J BellenDepartment of Neuroscience, Baylor College of Medicine, Houston, TX, 77030, USA.
Joshua M ShulmanDepartment of Neurology, Baylor College of Medicine, Houston, TX, 77030, USA. Joshua.Shulman@bcm.edu.
Baylor College of Medicine · USNeurological Research Institute · USThe University of Texas Medical Branch at Galveston · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
NRI Build-out: Advancing Translational Brain ResearchC06RR029965 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI ZOGHBI, HUDA Y · 2010 to 2010
$14.9M
Discovery of Novel Proteomic Targets in Alzheimer's DiseaseU01AG046161 · NIA · EMORY UNIVERSITY · PI BENNETT, DAVID ALAN, GESCHWIND, DANIEL H · 2014 to 2018
$8.4M
Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, SAMACO, RODNEY C · 2014 to 2019
$7.8M
Project 4: Pesticides and Genes In PD: Studies In HumansP01ES016732 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHESSELET, MARIE-FRANCOISE S · 2008 to 2012
$6.7M
Collaborative GWAS of Dementia, AD and related MRI and Cognitive EndophenotypesR01AG033193 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SESHADRI, SUDHA · 2009 to 2016
$4.4M
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's DiseaseR01AG050631 · NIA · BAYLOR COLLEGE OF MEDICINE · PI SHULMAN, JOSHUA M · 2016 to 2020
$2.5M
Exploring the Genetics of Alzheimer's Disease in Humans and DrosophilaK08AG034290 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SHULMAN, JOSHUA M · 2009 to 2013
$658k
Functional Validation of Parkinsons Disease Susceptibility Genes in DrosophilaR21NS089854 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI SHULMAN, JOSHUA M · 2014 to 2015
$435k
NCI NIH HHS P30 CA125123NCRR NIH HHS C06 RR029965NIA NIH HHS K08 AG034290NIA NIH HHS R01 AG033193NIA NIH HHS R01 AG050631NIA NIH HHS U01 AG046161NICHD NIH HHS U54 HD083092NIEHS NIH HHS P01 ES016732NINDS NIH HHS R21 NS089854
6 · The paper itself

Abstract

Common neurodegenerative proteinopathies, such as Alzheimer's disease (AD) and Parkinson's disease (PD), are characterized by the misfolding and aggregation of toxic protein species, including the amyloid beta (Aß) peptide, microtubule-associated protein Tau (Tau), and alpha-synuclein (αSyn) protein. These factors also show toxicity in Drosophila; however, potential limitations of prior studies include poor discrimination between effects on the adult versus developing nervous system and neuronal versus glial cell types. In addition, variable expression paradigms and outcomes hinder systematic comparison of toxicity profiles. Using standardized conditions and medium-throughput assays, we express human Tau, Aß or αSyn selectively in neurons of the adult Drosophila retina and monitor age-dependent changes in both structure and function, based on tissue histology and recordings of the electroretinogram (ERG), respectively. We find that each protein causes a unique profile of neurodegenerative pathology, demonstrating distinct and separable impacts on neuronal death and dysfunction. Strikingly, expression of Tau leads to progressive loss of ERG responses whereas retinal architecture and neuronal numbers are largely preserved. By contrast, Aß induces modest, age-dependent neuronal loss without degrading the retinal ERG. αSyn expression, using a codon-optimized transgene, is characterized by marked retinal vacuolar change, progressive photoreceptor cell death, and delayed-onset but modest ERG changes. Lastly, to address potential mechanisms, we perform transmission electron microscopy (TEM) to reveal potential degenerative changes at the ultrastructural level. Surprisingly, Tau and αSyn each cause prominent but distinct synaptotoxic profiles, including disorganization or enlargement of photoreceptor terminals, respectively. Our findings highlight variable and dynamic properties of neurodegeneration triggered by these disease-relevant proteins in vivo, and suggest that Drosophila may be useful for revealing determinants of neuronal dysfunction that precede cell loss, including synaptic changes, in the adult nervous system.

Indexed as

Agingalpha-SynucleinAmyloid beta-PeptidesAnimalsAnimals, Genetically ModifiedCell DeathDisease Models, AnimalDrosophilaElectroretinographyFemaleHumansMembrane PotentialsMicroelectrodesMicroscopy, Electron, TransmissionNeurodegenerative DiseasesNeuronsalpha-SynucleinAmyloid beta-Peptidesamyloid beta-protein (1-42)MAPT protein, humanPeptide FragmentsSNCA protein, humantau Proteinsalpha-synucleinAlzheimer diseaseAmyloid-beta peptideAnimal modelDrosophilaMAPTNeurodegenerationNeurophysiologyParkinson diseaseSNCASynapsesTau

Identifiers

PMID27338814
PMCPMC4918017
OpenAlexW2460790982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.